Literature DB >> 17290930

Proximal chromosome 11p contiguous gene deletion syndrome phenotype: case report and review of the literature.

B F M Romeike1, W Wuyts.   

Abstract

The proximal chromosome 11p contiguous gene deletion syndrome (P11pDS), also known as Potocki-Shaffer syndrome (PSS) or DEFECT 11 (OMIM 601224), is a disorder associated with foramina parietalia permagna and multiple osteochondroma (exostoses). Additional features include mental retardation, craniofacial anomalies, seizures and genitourinary abnormalities. Here, clinico-pathological findings of a unique patient with all of these features and, additionally, enlarged ventricles, hypertrophic obstructive cardiomyopathy and adipositas are described. The brain showed malformative lesions with hallmarks of disturbed bulk growth including micrencephaly, periventricular nodular heterotopias and focal cortical dysplasia in the nodulus of the cerebellar vermis. In addition, symmetric foci with vacuolation of the underlying neuropil, intermingled macrophages and large bizarre, partially vacuolated, reactive astrocytes were found. The proximal short arm of chromosome 11 harbors several candidate genes that could explain the patient's signs and symptoms including ALX4 and EXT2, which are always present in the interstitial deletion of the short arm of chromosome 11 in PSS. In addition, MYBPC3 would be a good candidate for the hypertrophic cardiomyopathy. Furthermore, adipositas might be related to the MAPK8IP1 gene. To the best of our knowledge, the present patient is the oldest one so far described with PSS phenotype and the only case that has undergone detailed neuropathological investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17290930     DOI: 10.5414/npp26001

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  5 in total

1.  Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies.

Authors:  Hyung-Goo Kim; Hyun-Taek Kim; Natalia T Leach; Fei Lan; Reinhard Ullmann; Asli Silahtaroglu; Ingo Kurth; Anja Nowka; Ihn Sik Seong; Yiping Shen; Michael E Talkowski; Douglas Ruderfer; Ji-Hyun Lee; Caron Glotzbach; Kyungsoo Ha; Susanne Kjaergaard; Alex V Levin; Bernd F Romeike; Tjitske Kleefstra; Oliver Bartsch; Sarah H Elsea; Ethylin Wang Jabs; Marcy E MacDonald; David J Harris; Bradley J Quade; Hans-Hilger Ropers; Lisa G Shaffer; Kerstin Kutsche; Lawrence C Layman; Niels Tommerup; Vera M Kalscheuer; Yang Shi; Cynthia C Morton; Cheol-Hee Kim; James F Gusella
Journal:  Am J Hum Genet       Date:  2012-07-05       Impact factor: 11.025

2.  Delayed Diagnosis of Potocki-Shaffer Syndrome in a Woman with Multiple Exostoses and Mental Retardation.

Authors:  C Palka; M Alfonsi; A Mohn; P Guanciali Franchi; F Chiarelli; G Calabrese
Journal:  Mol Syndromol       Date:  2012-04-27

3.  De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Authors:  Kohei Hamanaka; Yuji Sugawara; Takeyoshi Shimoji; Tone Irene Nordtveit; Mitsuhiro Kato; Mitsuko Nakashima; Hirotomo Saitsu; Toshimitsu Suzuki; Kazuhiro Yamakawa; Ingvild Aukrust; Gunnar Houge; Satomi Mitsuhashi; Atsushi Takata; Kazuhiro Iwama; Ahmed Alkanaq; Atsushi Fujita; Eri Imagawa; Takeshi Mizuguchi; Noriko Miyake; Satoko Miyatake; Naomichi Matsumoto
Journal:  Eur J Hum Genet       Date:  2018-11-28       Impact factor: 4.246

4.  Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.

Authors:  Ivy Jennes; Danielle de Jong; Kirsten Mees; Pancras C W Hogendoorn; Karoly Szuhai; Wim Wuyts
Journal:  BMC Med Genet       Date:  2011-06-26       Impact factor: 2.103

5.  Spectrum of genes involved in a unique case of Potocki Schaffer syndrome with a large chromosome 11 deletion.

Authors:  Bernd F M Romeike; Yiping Shen; Hiromi Koso Nishimoto; Cynthia C Morton; Lawrence C Layman; Hyung-Goo Kim
Journal:  Clin Neuropathol       Date:  2014 May-Jun       Impact factor: 1.368

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.